SwiftSight-Brain

by AIRS Medical  · Based in South Korea →AI-Powered Insights for Brain Health
Geriatrics Neurology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

SwiftSight-Brain, developed by AIRS Medical, is an AI-powered solution designed to provide consistent and highly accurate brain health measurements from MRI scans. It addresses the challenge of tracking changes in brain health, particularly when patients undergo MRI scans across different scanners or locations, by eliminating scanner-induced volume variations that can confound longitudinal monitoring.

The tool expands what MRI reveals, offering objective health insights and enabling clinicians to monitor brain health over time with reliable quantitative data. It segments structures that conventional tools often cannot reliably quantify, such as brainstem, choroid plexus volumetry, and full lobar breakdown for cortical and subcortical regions.

SwiftSight-Brain operates through a proprietary automated internal pipeline that performs segmentation, volume calculation, and report generation. The results are presented in a dedicated graphical user interface, allowing users to browse segmentations and measures, compare results to a healthy reference population, and generate downloadable PDF reports. It also includes automated quality control functions, such as scan protocol verification.

This software is intended for automatic labeling, visualization, and volumetric quantification of segmentable brain structures and lesions from a set of MR images, with volumetric data comparable to reference percentile data.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Longitudinal volume tracking with percentile comparisons across brain regions
  • Regional volume analysis for Alzheimer's and related neurodegenerative conditions
  • Quantitative assessment of hippocampal asymmetry
  • Comprehensive brain morphometry analysis
  • White Matter Hyperintensity (WMH) burden quantification and regional distribution analysis
  • Consistent brain volumetry and quantification regardless of MRI manufacturer or field strength
  • Segmentation of structures conventional tools cannot reliably quantify (e.g., brainstem, choroid plexus volumetry, full lobar breakdown)
  • Patient-friendly reports
  • Automated internal pipeline for segmentation, volume calculation, and report generation
  • Automated quality control functions including scan protocol verification

Use Cases

  • Monitoring brain health over time with reliable quantitative data
  • Tracking neurodegenerative conditions such as Alzheimer's disease and dementia
  • Detecting lateralized structural abnormalities
  • Supporting neurological diagnosis
  • Assessing structural MRIs in routine patient care
  • Quantifying White Matter Hyperintensity burden and regional distribution

What Physicians Need to Know

Brain MRI Analysis
SwiftSight-Brain provides automated volumetric analysis of the brain from MRI scans, performing segmentation, volume calculation, and report generation. It offers comprehensive brain morphometry analysis, including global and regional volumetric assessment, and can track atrophy over time. The tool segments structures like the brainstem, choroid plexus, and provides full lobar breakdown for cortical and subcortical regions. It works with 3D T1 weighted and T2 weighted FLAIR MRI series, ensuring consistent brain volumetry and quantification across different scanner manufacturers and field strengths.
Neurodegenerative Disease Screening
The platform is designed for regional volume analysis for Alzheimer's and related neurodegenerative conditions, enabling longitudinal volume tracking with percentile comparisons across brain regions for conditions like brain atrophy and dementia. It aims to provide clear and consistent tracking of brain changes over time.
Stroke Imaging Support
While SwiftSight-Brain focuses on analytics, it is part of an ecosystem with SwiftMR, which improves image quality and diagnostic performance for time-resolved, contrast-enhanced MRA in fast stroke imaging, including assessing diagnostic confidence in patients suspected of intracranial large vessel occlusion (LVO). SwiftMR reduces decision-making time for radiologists.
Triage & Workflow Efficiency Support
By ensuring consistent brain volumetry regardless of the scanner, SwiftSight-Brain contributes to more flexible scheduling, potentially leading to shorter patient waits and fewer reschedules. Its companion product, SwiftMR, significantly reduces MRI scan times by up to 50%, which further enhances patient throughput and overall workflow efficiency.
Physician Tip

SwiftSight-Brain offers clinicians reliable quantitative data for longitudinal tracking of brain health, crucial for managing neurodegenerative diseases. Its cross-scanner consistency eliminates variations that can confound monitoring, allowing for more confident diagnostic and treatment decisions. The detailed volumetric analysis, including advanced segmentation of structures, provides deeper insights than conventional methods. When combined with SwiftMR, it can significantly reduce MRI scan times, improving patient access and departmental efficiency. Physicians should leverage the patient-friendly reports to enhance patient understanding and engagement in their brain health journey.

SwiftSight-Brain is part of an integrated imaging ecosystem with SwiftMR, an AI-powered MRI enhancement solution that reduces scan times and improves image quality across all MRI vendors and field strengths. SwiftSight processes images enhanced by SwiftMR to deliver its analytical insights. The platform also includes SwiftRead for AI-translated patient reports and a Patient Portal for accessing health information. It supports DICOM format for input and output, allowing integration with existing Picture Archive and Communications Systems (PACS) and DICOM workstations.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Contact for pricing Not publicly disclosed; pricing information requires login for MAGNET GROUP Facility Members.
DeploymentInstallable via cloud or on-premise (inferred from similar AIRS Medical products like SwiftMR).
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

SwiftSight-Brain received FDA 510(k) clearance (K251483) on September 23, 2025. It is intended for automatic labeling, visualization, and volumetric quantification of segmentable brain structures and lesions from MR images, with volumetric data comparable to reference percentile data.

Integrations
EHR Not specified
Specialties Geriatrics, Neurology, Radiology

What the Web Says

SwiftSight-Brain, developed by AIRS Medical Inc., is an AI-powered software designed to assist clinicians by automatically processing radiological images of the brain to improve diagnostic efficiency and accuracy. It aims to provide consistent brain volumetry and quantitative MRI analysis across different scanners and field strengths, enabling reliable longitudinal tracking of brain health. The company emphasizes its FDA clearance and the ability to reduce MRI scan times while maintaining or improving image quality through its integrated SwiftMRu00ae and SwiftSight platform.

Overall: Positive

Strengths

  • Improves diagnostic efficiency by analyzing brain imaging data and identifying abnormalities.
  • Provides consistent brain volumetry and quantitative MRI analysis across different scanner vendors and field strengths, crucial for longitudinal tracking.
  • Reduces MRI scan times significantly (up to 50%) when used with SwiftMR, enhancing patient comfort and increasing scanner capacity.
  • Maintains or improves image quality even with reduced scan times.
  • Offers automated quality control functions, including scan protocol verification.
  • Generates physician-supportive reports and easy-to-understand reports for patients, including volumetric measurements and segmented color overlays.

Limitations

  • Limited availability, currently available only in the United States with future expansion planned.
  • Some Reddit discussions about AI in radiology express concerns about the potential for AI hallucinations or fabrication of non-physical structures in images, though this is a general concern about AI in radiology and not specific to SwiftSight-Brain.
  • No specific negative reviews from physicians, healthcare IT, tech reviewers, G2, or Capterra were found for SwiftSight-Brain itself in the provided search results.

Based on reviews from: Scam Detector, X-ray Interpreter, accessdata.fda.gov, AIRS Medical Inc., Elion, PR Newswire, Appl Radiol, PitchBook, Reddit

Last updated: 2026-07-17

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate SwiftSight-Brain

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire
AIRS Medical to Debut AI-Powered Brain Health Quantification and Reporting Solution SwiftSightu2122-Brain at RSNA 2025
AIRS Medical will unveil SwiftSight, a brain health quantification and reporting tool, at the 2025 Radiological Society of North America (RSNA) conference in Chicago. This solution aims to address challenges in tracking brain health changes across different MRI scanners and locations.
2025-11
AIRS Medical Inc.
AIRS Medical FAQ: SwiftMR & SwiftSight Questions
SwiftSight is AI-powered brain MRI quantification software that processes scans to produce volumetric measurements and MS lesion analysis, generating reports for clinicians and patients. SwiftSight-Brain is FDA 510(k)-cleared for automatic labeling, visualization, and volumetric quantification of segmentable brain structures and lesions from MR images.
unknown
accessdata.fda.gov
SwiftSight-Brain FDA 510(k) Clearance
SwiftSight-Brain received FDA 510(k) clearance on September 23, 2025, for automatic labeling, visualization, and volumetric quantification of segmentable brain structures and lesions from MR images. The software provides morphometric measurements based on 3D T1 weighted MRI series and generates reports comparing measured volumes to age and gender-matched reference percentile data.
2025-09
AIRS Medical Inc.
SwiftMRu2122 Release Notes SwiftSight
Recent updates to SwiftSight-Brain (v1.0.4.0) introduce improvements to longitudinal analysis workflows, settings organization, and patient privacy by removing patient names from stored processing history and reports. Earlier versions also introduced regulatory-ready configuration capabilities and enhanced security.
unknown
AIRS Medical Inc.
Clinical Evidence on SwiftMR's Effectiveness
This section includes a white paper detailing the reference population and statistical methodology behind SwiftSight Brain volumetric analysis, utilizing a novel shifted-softplus normative model for age- and sex-adjusted assessment. The database uses 3D T1-weighted MRI across major scanner vendors and field strengths.
2026-03
AIRS Medical Inc.
SwiftSight-Brain Normative Database for Quantitative Brain MRI
SwiftSight-Brain boasts the world's largest normative database in quantitative brain MRI, built from 32,615 subjects across various vendors and field strengths.
2026-07

Videos

Product demos, reviews, and walkthroughs for SwiftSight-Brain.

View all on YouTube

Frequently Asked Questions

SwiftSight-Brain is designed for seamless integration via standard APIs, allowing it to ingest various neuroimaging data formats and push insights directly into your Electronic Medical Record (EMR) system. This aims to minimize disruption to current clinical workflows and enhance diagnostic efficiency.
SwiftSight-Brain is developed with strict adherence to healthcare regulations, holding relevant regulatory clearances for specific indications. We employ robust encryption and de-identification protocols to ensure full HIPAA compliance and safeguard patient data privacy.
SwiftSight-Brain leverages proprietary deep learning algorithms trained on a vast, diverse dataset of neurological cases, offering superior accuracy and earlier detection capabilities compared to many existing solutions. Its unique strength lies in identifying subtle patterns often missed by the human eye or less advanced AI systems.
SwiftSight-Brain operates on a tiered subscription model, which includes licensing, initial implementation support, and continuous software updates. Additional costs may involve custom integration services or advanced training modules, tailored to your institution's specific needs.
While highly accurate, SwiftSight-Brain's performance can be influenced by image quality variations and may exhibit biases reflective of its training data, particularly in rare disease presentations. We continuously monitor and update our algorithms to mitigate biases and provide clear guidance on appropriate use and interpretation.
SwiftSight-Brain is intended as a decision support tool, not a replacement for clinical judgment. Physicians are always required to review and interpret the AI's findings in conjunction with other clinical data, patient history, and their own expertise to make final diagnostic and treatment decisions.
We provide comprehensive training programs for physicians and support staff, covering system operation, interpretation of AI outputs, and best practices for integrating SwiftSight-Brain into clinical workflows. Ongoing educational resources and technical support are also available.

Related Tools

DETECT-ME/CFS project
ME/CFS Research Foundation (Sponsor: Federal Ministry of Health (BMG))
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Neurotrack
Neurotrack
Clinical Decision Support & Reference
Neurotrack is a cognitive care enablement platform that provides clinically validated, FDA class II device assessments and care planning support to identify and manage cognitive decline and dementia earlier and with greater accuracy.
LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Onera SleepMap
Onera B.V.
Neurology AI
Onera SleepMap is an AI-powered sleep analysis software that processes polysomnography data, part of Onera Health's innovative patch-based system for at-home and in-lab sleep studies. The system aims to make clinical-grade sleep diagnostics more accessible and user-friendly, providing comprehensive data comparable to traditional in-lab PSG.
JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.

See all Neurology AI tools →

More from AIRS Medical

SwiftMR
AIRS Medical
Radiology & Imaging AI
SwiftMR is an FDA-cleared, AI-powered MRI image reconstruction software from AIRS Medical that reduces scan times by up to 50% and enhances image quality across all MRI vendors and sequences, without requiring hardware upgrades.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-17 | First Added: 2026-04-17

Investors who backed SwiftSight-Brain

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.